Viewing Study NCT04769895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-02-11 @ 3:40 AM
Study NCT ID: NCT04769895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-17
First Post: 2021-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
Sponsor: MaaT Pharma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Graft Versus Host Disease in Intestine View
None Steroid Refractory GVHD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Microbiotherapy View
None Fecal microbiota transfer View
None Gastro intestinal acute GVHD View
None ruxolinib refractory View